🇰🇷 South Korea Country × Condition
gastric cancer Clinical Trials in South Korea
Active clinical trials for gastric cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3, Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇰🇷 South Korea
Active Trials in South Korea (4)
NCT04787354 Phase 3
Recruiting
Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)
Enrollment
976 pts
Country
🇰🇷 South Korea
Hallym University Medical Center
View Trial → NCT05894824 Phase 1, Phase 2
Recruiting
T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Enrollment
58 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT06038578 Phase 2
Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Enrollment
146 pts
Country
🇰🇷 South Korea
Toray Industries, Inc
View Trial → NCT06695845 Phase 2
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Enrollment
200 pts
Country
🇰🇷 South Korea
Jazz Pharmaceuticals
View Trial → Frequently Asked Questions
How many gastric cancer clinical trials are active in South Korea?
There are currently 4 active clinical trials for gastric cancer with sites in South Korea, of which 4 are actively recruiting patients.
How can I join a gastric cancer clinical trial in South Korea?
To join a gastric cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are gastric cancer trials in South Korea?
Active gastric cancer trials in South Korea span Phase 3, Phase 1, Phase 2, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology